In Stage D heart failure, which therapy is generally not indicated because it can worsen symptoms?

Study for the WGU NURS6800 D116 Advanced Pharmacology Exam. Use flashcards and multiple-choice questions with hints and explanations. Prepare thoroughly for your exam!

Multiple Choice

In Stage D heart failure, which therapy is generally not indicated because it can worsen symptoms?

Explanation:
In end-stage heart failure, the focus is on relieving symptoms and avoiding medications that can further depress the heart’s function. Antidysrhythmic medications often have negative inotropic effects and can prolong the QT interval, increasing the risk of dangerous arrhythmias. In Stage D, where the heart already struggles to maintain adequate output, these risks mean antiarrhythmic drugs can worsen symptoms and overall stability, making them generally not indicated. Other therapies like diuretics to reduce congestion and agents that support remodeling and afterload (when feasible) are favored to improve quality of life.

In end-stage heart failure, the focus is on relieving symptoms and avoiding medications that can further depress the heart’s function. Antidysrhythmic medications often have negative inotropic effects and can prolong the QT interval, increasing the risk of dangerous arrhythmias. In Stage D, where the heart already struggles to maintain adequate output, these risks mean antiarrhythmic drugs can worsen symptoms and overall stability, making them generally not indicated. Other therapies like diuretics to reduce congestion and agents that support remodeling and afterload (when feasible) are favored to improve quality of life.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy